Eur J Gastroenterol Hepatol . 2026 Jan 1;38(1):36-41.

doi: 10.1097/MEG.0000000000003083. Epub 2025 Nov 26.

Rate and predictors of successful antitumor necrosis factor deescalation after dose intensification in inflammatory bowel disease patients: a real-world Greek-Turkish collaborative study

Nikos Viazis¹, Murat Toruner², Vasilios Papastergiou¹, Konstantinos Mousourakis¹, Angeliki Christidou¹, Maria Tzouvala³, Eirini Zacharopoulou³, Maria Palatianou³, Georgios Theocharis⁴, Georgios Geramoutsos⁴, Angeliki Theodoropoulou⁵, Konstantinos Karmiris⁵, Magdalini Velegraki⁵, Aykut Ferhat Çelik⁶, Atilla Akpinar⁶, Evanthia Zampeli⁷, Evgenia Papathanasiou⁷, Nalan Gulsen Unal⁸, Andreas Kapsoritakis⁹, Konstantinos Argyriou⁹, Dimitrios Christodoulou¹⁰, Konstantinos Katsanos¹⁰, Fotios Fousekis¹⁰, Tarkan Karakan¹¹, Ioannis E Koutroubakis¹², Ioannis Drygiannakis¹², Olga Giouleme¹³, Maria Kalogirou¹³, Evangelina Vlachou¹³, Christos Liatsos¹⁴, Nikolaos Kyriakos¹⁴, Eftychia Tsironi¹⁵, Panagiotis Markopoulos¹⁵, George Bamias¹⁶, Konstantina Chalakatevaki¹⁶, Georgia Tsiolakidou¹⁷, Charikleia Lamouri¹⁷, George Tribonias¹⁸, Konstantina Dimopoulou¹⁸, Panagiotis Kasapidis¹⁹, Konstantina Paraskeva²⁰, Pelin Telli²¹, Filiz Akyuz²¹